- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06126926
Tertiary Prevention of Child Sexual Abuse
January 5, 2026 updated by: University of Minnesota
Mobilizing Evidence Into Tertiary Prevention of Child Sexual Abuse: A Pilot Study
This is a feasibility study designed to inform the development of a multinational study of the effectiveness of a tertiary prevention program for child sexual abuse.
This study targets adult men who have engaged in child sexual abuse, and will be implemented within the Minnesota Department of Corrections.
Data will include measures of the implementation process, short-terms changes in criminogenic factors, and staff and participant factors that could influence outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55414
- University of Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Male
- 18 or older
- Serving time in MnDOC facilities for Criminal Sexual Conduct in the first, second, or third degree, whose victims were less than 14 years old
- Individuals assigned moderate to high risk to reoffend as determined upon entrance to the Minnesota Correctional System by the DOC Risk Assessment/Community Notification Unit."
Exclusion Criteria:
- Diagnosed with an active, uncontrolled major mental disorder (e.g. bi-polar, schizophrenia, schizoaffective disorder, major depression with psychotic features)
- Unable to read English at the 5th grade level
- Unable to speak English
- IQ of less than 85 as measured by standard intelligence tests
- Diagnosis of intellectual disability
- Engaged in violent behavior while incarcerated, as indicated by disciplinary actions and/or segregation within 60 days of intake"
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention arm
32-week group therapy
|
32 weeks of group therapy
|
|
Active Comparator: Control group
Treatment as Usual
|
Control participants remain in their current placement and may be eligible for a number of services offered to inmates to facilitate rehabilitation and planning for release to the community, including sexual offender treatment.
MnDOC's sexual offender treatment is a two to three year program, thus most of our control subjects will not have enough time remaining on their sentences to complete such treatment.
However, a number of them may participate in MnDOC's current program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Violence Risk Scale-Sexual Offense Version (VRS:SO)
Time Frame: 7 days post-intervention
|
Clinician rating scale.
24-items measuring likelihood of sexual offense recidivism using a 4 point scale.
|
7 days post-intervention
|
|
Coping Using Sex Inventory (CUSI)
Time Frame: 7 days post-intervention
|
Self-report scale.
16 items measuring consensual, non-consensual, and child-focused sexual coping strategies using a 5-point scale
|
7 days post-intervention
|
|
Compulsive Sexual Behavior Inventory-13 (CSBI-13)
Time Frame: 7-days post-intervention
|
Self-report scale.
13 item scale measuring the presence of compulsive sexual behaviors on a 5- point scale.
|
7-days post-intervention
|
|
Types of Jealousy Scale (3 subscales; reactive, preventive, and anxious jealousy)
Time Frame: 7 days post-intervention
|
Self-report scale.
15 items measuring the intensity of reactive jealousy, experience and use of preventive jealousy, and frequency of anxious jealousy on a 5-point scale.
|
7 days post-intervention
|
|
Faith in People Scale
Time Frame: 7 days post-intervention
|
Self-report scale.
5 item scale measuring attitudes toward human nature.
Two forced- choice items and three agreement/disagreement items.
|
7 days post-intervention
|
|
Trust in People Scale (Survey Research Center)
Time Frame: 7 days post-intervention
|
Self-report scale.
3 item scale measuring perception of general trustworthiness of others.
|
7 days post-intervention
|
|
Aggression Questionnaire (AQ; Buss &) - Physical Aggression, Verbal Aggression, and Anger Subscales ONLY
Time Frame: 7 days post-intervention
|
Self-report scale.
21 items throughout the 3 subscales measuring how characteristic physical aggression, verbal aggression, and anger-related behaviors are for respondents on a 7 point scale.
|
7 days post-intervention
|
|
Revised UCLA Loneliness Scale (R-UCLA)
Time Frame: 7 days post-intervention
|
Self-report scale.
20 items measuring subjective feelings of loneliness and social isolation on a 4 point scale.
|
7 days post-intervention
|
|
Self-Critical Rumination Scale (SCRS)
Time Frame: 7 days post-intervention
|
Self-report scale.
10 items measuring self- criticism on a 4 point scale.
|
7 days post-intervention
|
|
External/Internal Shame Scale - Sense of Isolation/Exclusion Subscale ONLY (EISS)
Time Frame: 7 days post-intervention
|
Self-report scale.
Measures perceived sense of exclusion and being isolated or misunderstood by people on a 5 point scale.
|
7 days post-intervention
|
|
Children and Sex Questionnaire Emotional Congruence Scale (CSQ:ECWC)
Time Frame: 7 days post-intervention
|
Self-report scale.
15 item scale measuring emotional congruence with children on a 5 point scale.
|
7 days post-intervention
|
|
The Openness to Men and Women Scales (OPM, OPWO)
Time Frame: 7 days post-intervention
|
Self-report scale.
18 items assessing openness to intimacy with women and men on a 4 point scale.
|
7 days post-intervention
|
|
Difficulties in Emotion Regulation Scale - Short Form (DERS-SF)
Time Frame: 7 days post-intervention
|
Self-report scale.
18 items measuring problems with emotion regulation including subscales for strategies, non-acceptance, impulse, goals, awareness, and clarity on a 5 point scale.
|
7 days post-intervention
|
|
Coping Strategy Indicator (CSI)
Time Frame: 7 days post-intervention
|
Self-report scale.
33 items measuring adaptive and maladaptive coping strategies (avoidance, problem-solving, social support seeking) on a 3 point scale.
|
7 days post-intervention
|
|
Aggression Inventory (AI)- Impulsive, Impatient, and Avoid subscales ONLY
Time Frame: 7 days post-intervention
|
Self-report scale.
22 item scale measuring perceptions and use of aggressive behaviors for men a women on a 5 point scale.
|
7 days post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Group Climate Questionnaire - Short Form (GCQ-5)
Time Frame: Every 14 days for first two months, than every four weeks for next four months
|
Self-report scale.
12 items measuring group perceptions of the group therapeutic environment on a 7 point scale.
|
Every 14 days for first two months, than every four weeks for next four months
|
|
Curative Climate Instrument (CCI)
Time Frame: Every 14 days for first two months, than every four weeks for next four months
|
Self-report scale.
14 items measuring specific change processes perceived as helpful to individual group members (catharsis, insight, and cohesiveness) on a 5 point scale.
|
Every 14 days for first two months, than every four weeks for next four months
|
|
Treatment Motivation Questionnaire-Revised (TMQ-R)
Time Frame: Every 14 days for first two months, than every four weeks for next four months
|
Self-report scale.
23 items measuring internal and external reasons for participating in treatment, motivations relating to connecting and sharing with others, and clients' potential lack of confidence in treatment on a 7 point scale.
|
Every 14 days for first two months, than every four weeks for next four months
|
|
Therapeutic Agency Inventory (TAI)
Time Frame: Every 14 days for first two months, than every four weeks for next four months
|
Self-report scale.
15 items measuring clients' experience of agency in making positive change and ability to take an active role in their therapy on a 5 point scale.
|
Every 14 days for first two months, than every four weeks for next four months
|
|
Relationship Questionnaire (RQ)
Time Frame: Every 14 days for first two months, than every four weeks for next four months
|
Self-report scale.
4 items measuring adult attachment style on a 7 point scale.
|
Every 14 days for first two months, than every four weeks for next four months
|
|
Working Alliance Inventory - Short Form (WAI- SR)
Time Frame: Every 14 days for first two months, than every four weeks for next four months
|
Self-report scale.
12 items measuring three domains of the therapeutic alliance: goals, tasks, and bond on a 5 point scale.
|
Every 14 days for first two months, than every four weeks for next four months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael Miner, Ph.D, University of Minnesota
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 31, 2024
Primary Completion (Actual)
May 14, 2025
Study Completion (Actual)
December 31, 2025
Study Registration Dates
First Submitted
October 16, 2023
First Submitted That Met QC Criteria
November 6, 2023
First Posted (Actual)
November 13, 2023
Study Record Updates
Last Update Posted (Actual)
January 7, 2026
Last Update Submitted That Met QC Criteria
January 5, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMCH-2023-32331
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Child Sexual Abuse
-
Oral Health Centre of Expertise in Western NorwayEducational storytelling forlag og filmCompletedChild Abuse | Oral Health | Child Neglect | Child Maltreatment | Child Sexual Abuse | Dental NeglectNorway
-
Johns Hopkins Bloomberg School of Public HealthUniversity of Massachusetts, Lowell; Barry UniversityCompletedChild Sexual Abuse | Program Evaluation | Perpetration of Child Sexual Abuse | Prevention InterventionUnited States
-
Center for Violence Prevention Research IncRecruiting
-
New York UniversityTerminatedChild Sexual AbuseUnited States
-
Northeastern UniversityEnrolling by invitation
-
Penn State UniversityCompleted
-
Anne Revah-LevyRecruitingChild Sexual AbuseFrance
-
New York UniversityRecruitingChild Sexual AbuseUnited States
-
The New York Society for the Prevention of Cruelty...National Institutes of Health (NIH)CompletedSafe Touches: A Rigorous Evaluation of a Sexual Abuse Prevention Program for Children (Safe Touches)Child Sexual AbuseUnited States
Clinical Trials on group therapy
-
Meir Medical CenterUnknown
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
Gaziosmanpasa Research and Education HospitalCompletedDuchenne or Becker Muscular DystrophyTurkey
-
Peking University Cancer Hospital & InstituteNot yet recruitingLocalized Small Cell Lung CancerChina
-
US Department of Veterans AffairsCompleted
-
Chinese University of Hong KongYangzhou UniversityCompletedAnxiety | Social Connectedness | Emotional Well-BeingChina
-
Bar-Ilan University, IsraelMaccabi Healthcare Services, IsraelCompletedDepression | PTSD | Stress | Fibromyalgia | Sleep DisturbanceIsrael
-
University of North GeorgiaCompletedHip Alignment and Shoulder Rotation
-
Brown UniversityNational Institute of Mental Health (NIMH)TerminatedBehavior Problems | Emotional DistressUnited States
-
Paolo PillastriniCompletedTemporomandibular DisorderItaly